tiprankstipranks

Novocure reports Q1 EPS (31c), consensus (46c)

Reports Q1 revenue $154.99M, consensus $147M. “This is a period of meaningful momentum for Novocure (NVCR),” said Ashley Cordova, CEO Novocure. “After years in a single commercial indication, our footprint is expanding across new indications, new centers, and new physician specialties. Our lung launch is progressing. Our pipeline is advancing. And our commitment to patient-forward innovation is stronger than ever. We look forward to updating you on our progress as the year unfolds.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue